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a  b  s  t  r  a  c  t
Objective: Revision of the state of the art of the knowledge regarding pathophysiology, diag-
nosis and treatment of Colonic Inertia, which predominantly affects young women and has
a  signiﬁcant socio-economic impact.
Methods: A search was made in “colonic inertia”, “colon inertia” and “slow transit consti-
pation” in PubMed database for articles of the last 5 years, in Portuguese or English with
available abstract and full text. 59 articles and 2013 guidelines of the American Gastroen-
terological Association on constipation were included.
Results: The pathophysiology is not completely elucidated and the reduction of the intersti-
tial  cells of Cajal is the most consistent histological ﬁnding. Diagnosis requires the exclusion
of  secondary causes of constipation and obstructed defecation syndrome, to which con-
tribute several complementary diagnostic tests. Given the frequency of failure of the medical
treatment, surgery is often the only possible option. Sacral nerve stimulation seems to be a
promising therapeutical alternative.
Conclusion: A deeper investigation of the pathophysiological mechanisms is fundamental to
acquire a more global and integrated vision. Rigorous patient selection for each treatment
and the discovery of new therapeutical targets may avoid the use of surgical therapies.
© 2016 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de
Coloproctologia. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Objetivo: Revisão do estado da arte do conhecimento da patoﬁsiologia, diagnóstico e trata-





Métodos: Pesquisou-se na base de dados PubMed por “colonic inertia”, “colon inertia” e “slow
transit constipation” por artigos apenas dos últimos 5 anos, em português ou em inglês com
resumo e texto completo disponíveis. Incluíram-se 59 artigos e as recomendac¸ões de 2013
da  Associac¸ão Americana de Gastroenterologia para a obstipac¸ão.
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Resultados: A patoﬁsiologia ainda não está completamente esclarecida, sendo que a reduc¸ão
das células intersticiais de Cajal constitui o achado histológico mais consistente. O diag-
nóstico requer a exclusão de causas secundárias de obstipac¸ão e de síndrome de obstruc¸ão
defecatória, para o qual contribuem vários exames complementares de diagnóstico. Dada
a  frequência do insucesso do tratamento médico, a cirurgia é, muitas vezes, a única opc¸ão
possível. A estimulac¸ão nervosa sagrada parece ser uma alternativa terapêutica promissora.
Conclusão: É fundamental uma investigac¸ão mais profunda dos mecanismos patoﬁsiológicos
envolvidos para adquirir uma visão mais global e integrada. A selec¸ão rigorosa de pacientes
para cada tratamento e a descoberta de novos alvos terapêuticos poderão evitar a utilizac¸ão
de terapêuticas cirúrgicas.
© 2016 Publicado por Elsevier Editora Ltda. em nome de Sociedade Brasileira de
Coloproctologia. Este e´ um artigo Open Access sob uma licenc¸a CC BY-NC-ND (http://Introduction
Severe/intractable colic inertia or slow transit constipation is
the inability that the colon has to modify stool consistency, so
as to make them move from the cecum to rectosigmoid at least
once every three days. There is a signiﬁcant delay in colonic
transit, not attributable to any other cause.1–4
Slow transit constipation is responsible for a variable per-
centage (13–37% in recent studies) of cases of idiopathic
chronic constipation (lasting more  than 3 months). This con-
dition is classiﬁed as a functional one according to ROME
III criteria, contrary to the American Gastroenterological
Association.5–11
The condition predominantly affects young women and
has a signiﬁcant economic impact.6,11–14
In addition to constipation, a lack of desire to defecate,
abdominal distension, abdominal pain, feeling of incomplete
evacuation, nausea, and decreased food intake may also be
present.11,15
The diagnosis is established by clinical examination and
ancillary diagnostic tests, including colonic transit studies;
but these procedures are not sufﬁcient to select patients with
a view to the most appropriate treatment. The treatment of
slow-transit constipation is not standardized, and the fail-
ure of medical treatment (which often occurs) is a surgical
indication. But surgery, though with potential good functional
results, cannot solve all the symptoms.8,16,17
One must know the pathophysiology of this entity in order
to give the best treatment for each patient, with the help of
complementary diagnostic tests.
Methods
The search for this review was conducted in July and August
2015, and PubMed was the database used. “Colonic inertia,”
“colon inertia,” and “slow transit constipation” were searched,
always using as ﬁlters the abstract and full-text availability,
articles from the last ﬁve years, and articles only in Portuguese
and English. Seventeen, 11 (7 repeated) and 100 articles (6Please cite this article in press as: Soares AS, Barbosa LE. Coloni
http://dx.doi.org/10.1016/j.jcol.2016.05.006
repeated) were obtained, respectively. Of these 115 articles,
we did not have access to one. After reading and analyz-
ing these 114 articles, 59 were selected for their relevance
and importance to the subject studied. The 2013 Americancreativecommons.org/licenses/by-nc-nd/4.0/).
Gastroenterological Association recommendations for consti-
pation were also included.
Pathophysiology
In order to have a normal bowel function, there must be
integrity of the gut–brain–microbiome axis. Suppose if prob-
lems can occur at any level, some more  get localized (at the
colon wall level), other get more  widespread. Manometric
studies have shown that colonic motor activity is a complex,
intermittent, and variable in time and space phenomenon,
and this occurs also among different segments of the colon. It
is known that in cases of slow transit constipation there is a
change of intestinal motility, in terms of frequency, amplitude
and duration, but the underlying mechanisms are not well
known. Various explanations of possible etiologies related to
myopathy, neuropathy (myenteric plexus, changes in the lev-
els of neuroendocrine transmitters, central neuropathy), or a
reduction of the interstitial cells of Cajal have been proposed,
and seemingly the latter proposition is the most consistent
histological ﬁnding. There have been several observations that
support every possible etiology.8,16–19
Decrease  of  spontaneous  high-amplitude  propagating
sequences,  after  meals  and  upon  waking
The high-amplitude propagating sequences are one of several
motor patterns observed in healthy individuals. They corre-
spond to the mass movements in the colon that occur after
food intake (gastrocolic reﬂex), consisting of a set of pressure
events that always progress in an anterograde direction and
whose maximum amplitude is, in most cases, >116 mmHg.
Most of them originate in the proximal colon, propagating
by varying distances, and do not spread beyond half of the
colon; <5% reach the rectum. The sequences (in fasting, or
postprandial) occur spontaneously in response to pharmaco-
logical agents or to the distention of the colon, increasing in
number when the person wakes up (the sequences are mostc Inertia: approach and treatment. J Coloproctol (Rio J). 2016.
common during the day) and after meals. They have a speed
of propagation of 1–2 cm/s in the right colon, increasing as
the waves advance caudally, often reaching synchronicity, and
followed by defecation.20–22
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As the central nervous system appears to play a role in
ncreasing the propagation pressure after meals and in induc-
ng their nocturnal suppression, a decreased or inhibited
esponse to these stimuli, such as that found in cases of
low transit constipation, possibly suggests a neuropathy, or
yopathy. Moreover, this reduced response also suggests the
ossible involvement of clock genes, which are central or
eripheral (in colonic epithelium and myenteric plexus) and,
n turn, can control directly or indirectly colonic gene groups
hat regulate motility. In slow transit constipation, one can
lso observe a decreased response to chemical stimuli, for
xample, to bisacodyl, which may indicate a neuromuscular
ysfunction; this can draw attention, more  speciﬁcally, to a
hange of the myenteric plexus, in the cholinergic pathways,
r in colonic and rectal neural pathways.14,19,20,23
ecrease  in  the  number  and  frequency  of  cyclic  motor
atterns  after  high-calorie  meals
yclic motor patterns are another type observed in healthy
ubjects. These are repetitive propagating pressure events
ith a cyclic frequency of 2–6 min−1 (corresponding to slow
aves) which, for the most part, are observed in the sigmoid
olon and which can progress in an anterograde or retrograde
irection. These patterns increase in number after meals. The
etrograde cyclic motor patterns stand out; their function is to
revent a premature rectal ﬁlling and provide sufﬁcient time in
rder to allow the reabsorption of water and electrolytes dur-
ng the formation of feces. It is believed that the interstitial
ells of Cajal are the source of these patterns, which are mod-
lated by excitatory stimuli. Therefore, the observation of a
ecreased post-prandial response also suggests the existence
f an extrinsic neuropathy, namely parasympathetic (extrinsic
ympathetic stimuli inhibit the intestinal motility) neurop-
thy. Another study failed to get a response after applying an
lectric or distensible stimulation, suggesting the existence of
 problem intrinsic to the colon of the patients in the enteric
ervous transmission.20,21,24
hanging  the  spatial–temporal  organization  of
ropagating  sequences
he propagating sequences are organized so as to allow a con-
inuous ﬂow. Slow transit appears to be documented more
requently in the left colon than in the ascending and trans-
erse colon. A pan-colonic spatial–temporal mapping study
sing manometry even showed a decrease in the propagating
xtension of the waves  originating from the proximal colon,
nd an increase of the frequency of retrograde propagating
equences in the proximal colon, suggesting the existence
f an adynamic zone at the level of the splenic angle, corre-
ponding to the junction zone of two different embryological
egments and, therefore, possibly with a disruption of the
nnervation zone (probably more  important in subjects with
onstipation at a very early age). It is assumed that the
olonic vagal innervation ends at the level of the splenic angle.Please cite this article in press as: Soares AS, Barbosa LE. Coloni
http://dx.doi.org/10.1016/j.jcol.2016.05.006
he remainder of the colon and the rectum receive sensory
nnervation from pelvic nerves. The absence of the normal
uppression of nocturnal waves  also suggests a central neu-
opathic cause.7,14,20,22;x x x(x x):xxx–xxx 3
Decrease  of  interstitial  cells  of  Cajal
Interstitial cells of Cajal are considered as intestinal pacemak-
ers, playing a critical role in the regulation of spontaneous
electrical activity (“slow waves and enteric transmission”).
These cells can be found particularly at the level of mucosa
and myenteric plexus. Despite the frequent observation of
their decrease in histologic ﬁndings in patients with slow
transit constipation, there is still doubt whether this is a pri-
mary  cause, or if it is a secondary change. Together with this
decrease, a reduction in enteric nerves and hypoganglionosis
are ﬁndings also often observed, suggesting two  possibilities:
the existence of a factor that induces both decreases, or the
decreases inﬂuence their mutual survival.9,15,17,18
Other  observations
Other changes have been observed in patients with slow
transit constipation. The endocannabinoid system has a con-
troversial role in the regulation of intestinal motility and
may be bidirectional. However, a decrease in fatty acid amide
hydrolase (FAAH) activity would lead to an increase of two
endocannabinoids: anandamide and 2-araquidonilglicerol (2-
AG) which, through their action on cannabinoid receptor type
1 (CB1), would lead to a reduction of intestinal motility.25
The brain-derived neurotrophic factor (BDNF) appears to inﬂu-
ence the maintenance and survival of the enteric nervous
system, accelerating the colonic emptying and increas-
ing the frequency of bowel movements. Studies in mice
have suggested that a change of BDNF would lead to a
change in the neural structure of the intestinal innervation,
with denervation, causing atrophy and secondary smooth
muscle degeneration [with a decrease in smooth muscle -
actin (-AML) expression] through the kinase tropomyosin
B receptor-phospholipase C/inositol triphosphate (TrkB-PLC-
IP3) pathway. A decrease of this factor in human patients has
been demonstrated.26 An increase in the number of intact
(not degranulated) mast cells in the colon of these patients
was also observed, but it was suggested that this would be
a potential compensatory mechanism, in order to repair any
damaged neuroenteric circuits, taking into account that they
constitute a source of nerve growth factors.27 Furthermore,
a study with mice suggested that mast cell deﬁciency could
lead to an inﬂammatory condition that would decrease muscle
contractility by reducing the reactivity to acetylcholine (Ach),
regardless of the decrease in the number of the interstitial cells
of Cajal.28 Apparently, the peptide YY (PYY) is increased in the
ascending colon in some patients, constituting a possible eti-
ological factor, by leading to an increased absorption and to
a decreased secretion of water and electrolytes, and resulting
in an increase of the ileal brake force and in the inhibition
of intestinal motility.29 The downregulation of microRNA128
in the colon of these patients appears to lead to increased
numbers of macrophages, which could lead to loss or dys-
function of the interstitial cells of Cajal.9 A decrease in thec Inertia: approach and treatment. J Coloproctol (Rio J). 2016.
expression of esmotelin, that supposedly plays a role in mus-
cle contractile activity by interacting with -MLA in the outer
layer of the muscularis propria, may have implications in the
pathogenesis of colic inertia in some patients.30
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Role  of  progesterone
There is evidence that colonic transit is more  intense dur-
ing the luteal phase of the menstrual cycle, and that the
speed of propagation of phase III of the migrating motor
complex is slowed in women. Although women with slow
transit constipation have normal levels of progesterone, there
appears to be an overexpression of progesterone recep-
tors in the circular muscle layer of the colon, which slows
its contractility. Progesterone activates two nuclear recep-
tors, A and B. The stimulation of A receptors increases
muscle relaxation induced by vasoactive inhibitory pep-
tides, whereas the stimulation of B receptors down-regulates
cyclooxygenase-1 (COX-1) and decreases thromboxane A2
(TXA2) and prostaglandin F2 (PGF-2)  levels, which would
lead to muscle contraction. This latter receptor appears to
be responsible for which normal muscle cells will respond to
physiological concentrations of progesterona.31,32
Diagnosis
Clinical  diagnosis
The initial approach of a chronically constipated patient
consists in taking a comprehensive collection of medical
history and in a thorough physical examination. It is impor-
tant that, as early as possible, warning symptoms and
signs (weight loss, blood loss, and family history of colon
carcinoma) and secondary causes (improper diet, lack of
physical activity, use of pharmaceutical agents, metabolic dis-
eases, psychiatric or neurological disorders, complications of
perineal–pelvic–abdominal or obstetric–gynecologic surgery)
are excluded. It is particularly important that malignancy in
older patients is excluded.2,17
It may be useful to apply the Wexner constipation scale
that simpliﬁes and objectify complaints, and the Constipation
Severity Instrument (CSI) which, in addition to identifying the
various types of constipation, also scores its severity; on the
other hand, to assess the impact of constipation on quality
of life, the SF-36 questionnaire and the Constipation-related
quality of life (CRQOL) are useful tools.2,11,12,17,33 The Rome III
Criteria for the Diagnosis of Functional Constipation and the
Bristol stool scale (a classiﬁcation based on the shape of feces)
are also emphasized.2,7,11,34,35
Complementary  diagnostic  tests
In an initial approach, a complete blood count should be
obtained; there is controversy if biochemical tests would be
of interested.10,17,36
Colonoscopy  and  barium  enema
Colonoscopy allows a structural evaluation of the colon and
excludes anatomical/mechanical causes of constipation. ThisPlease cite this article in press as: Soares AS, Barbosa LE. Coloni
http://dx.doi.org/10.1016/j.jcol.2016.05.006
test should be done particularly if the patient has warning
symptoms, shows a sudden onset of constipation, or if is aged
over 50 and have never done a colorectal cancer screening. The
colonoscopy also allows the achievement of biopsy samples6;x x x(x x):xxx–xxx
(ideally reaching the muscular layer) to evaluate histological
changes.
A barium enema may be indicated in cases of a difﬁcult
bowel preparation and of colonic tortuosity.1,10,17,36
Defecography,  anorectal  manometry  and  balloon  expulsion
test
It would seem that a signiﬁcant overlap occurs between slow
transit constipation and constipation caused by pelvic ﬂoor
changes. The differential diagnosis is essential to delineate
an appropriate therapeutic strategy.
Defecography is a dynamic morphological radiological
study that provides information about the anatomical and
functional changes that occur in the anus and rectum
at rest and during defecation. This test identiﬁes several
causes of failure in the evacuation (defecatory dyssyner-
gia, defecatory obstruction). The pelvic dynamic MRI is an
alternative.
Anorectal manometry is a very useful tool in the inves-
tigation of anorectal physiology: it evaluates the sphincter
pressure at rest, during contraction, and during a defeca-
tion effort. The balloon expulsion test can also measure the
anorectal coordination during defecation. In analyzing the
action potentials of the pelvic muscles, electromyography pro-
vides further information.1,2,4,37–39
Transit  studies
The most commonly used test for diagnosis of slow transit
constipation is the transit study, which relies on the mea-
surement of transit speed. The patient should refrain from
taking laxatives, enemas or suppositories, and should report
any bowel movement  as long as the test is on. The test
consists of the intake of 24 radiopaque markers on day 0
and obtaining abdominal radiographs on days 1, 3 and 5. If
there are 5 or more  markers in the colon at day 5, i.e. more
than 20% retention of markers or no expulsion of more  than
80% of the markers, the existence of slow transit constipa-
tion is documented. This test allows distinguishing patients
with segmental or total slow transit, depending on the site
of accumulation of radiotracers. If the markers are scattered
throughout the colon but with accumulation especially in
the ascending colon, the patient will probably have colic
inertia. If the accumulation of markers predominates in the
rectosigmoid region, then this is probably a case of defe-
catory obstruction. Many variations of this test have been
already described, particularly with respect to the number
of ingested markers and the number of radiographs, which
can complicate the subsequent comparison of results. The
protocol developed by Metcalf, that is, the intake of 3 differ-
ent types of markers on 3 separate days (0, 1, and 2), with
radiography obtained on day 4 and, if necessary, also on day
7 (which will be more  useful for the diagnosis of segmen-
tal areas of colic inertia), is emphasized. Some studies have
replaced the use of radiotracers by barium suspensions and
suggested that these suspensions, in addition to being cheapc Inertia: approach and treatment. J Coloproctol (Rio J). 2016.
and simple, may allow a more  accurate measurement of bowel
transit in the various intestinal segments since they blend bet-
ter with the contents of the gastrointestinal tract and allow
a more  exact deﬁnition of the location of the suspension.
ARTICLE IN PRESSJCOL-183; No. of Pages 9
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 disadvantage of these methods is the higher radiation
xposure.1,2,12,15,37,40–42
olon  manometry
olon manometry is of interest in the diagnosis and to
he therapeutic decision-making, which should not be based
xclusively on radiologic studies. This test shows the daily
otor patterns of bowel activity by measuring multiple
egions of the colon, and changes in their characteristics help
o characterize dysmotility. This technique has undergone
hanges which mainly consist in increasing the number of
ata-collection sensors into the colon and in reducing the
pacing between these sensors, namely, the low-resolution
anometry becomes a high-resolution test. Taking into
ccount that the motor patterns are not evenly distributed
hroughout the colon, this resulted in an increase in our power
o correctly identify the propagating events and their direction
nd frequency. Colon manometry reveals that there is a signif-
cant pathophysiological heterogeneity among patients with
low transit constipation, dividing them into three subtypes
ased on three physiological responses: high-amplitude prop-
gating contractions, gastrocolic response, and colic response
hen awakening. If two of these three responses are absent,
his suggests neuropathy (probably caused by nerve circuit
amage, with secondary muscle dysfunction). If two or three
esponses are present, but in an attenuated form (pressure
ctivity less than two standard deviations from the normal
otor response), then this will suggest myopathy (probably
aused by target organ or muscle damage, but with intact
eural circuits). If the 3 responses are present, or if there
s a slight change of only one of two responses, the mano-
etric pattern is considered normal. A relationship between
hese patterns and the clinical evaluation and transit stud-
es has not been established. Thus, it can be concluded
hat manometry is particularly important for refractory slow
ransit constipation, serving as a guide for subsequent treat-
ent; and this technique may also predict the therapeutic
ffectiveness.
To assess colonic tone and sensitivity, one can connect a
arostat in the manometer. This procedure is useful because
tudies show that, in addition to motor dysfunction, a sensory
ysfunction – or even an isolated sensory neuropathy – may
lso be present. However, this may also be only an effect, not
 cause.
Challenge studies with bisacodyl or neostigmine may be
seful to test the residual propulsive activity, thus helping in
 proper selection of patients with severe colic inertia or with
low transit constipation for surgery.8,17,19,42–44
cintigraphy  and  capsule  endoscopy
cintigraphy and capsule endoscopy are more  advanced, but
ore expensive, methods, which limits their application.Please cite this article in press as: Soares AS, Barbosa LE. Coloni
http://dx.doi.org/10.1016/j.jcol.2016.05.006
hese methods allow measuring gastric, small intestine, and
olon transit times in a single test; thus, these tests are
mportant to assess the regional transit time and exclude a
uspected gastrointestinal diffuse dysmotility. This informa-
ion may have prognostic signiﬁcance in predicting the results
f aggressive therapies.2,40,45,46;x x x(x x):xxx–xxx 5
Treatment
Conservative  measures
The ﬁrst line of treatment in cases of chronic constipation is
to change behavior, with modiﬁcation of the lifestyle and diet.
These patients should be advised to discontinue drugs that
can cause secondary constipation, not to postpone defeca-
tion when they feel comfortable, and to defecate every day
at the same time, preferably in the morning upon waking and
after meals. It is known that constipation is more  frequent
in subjects with a sedentary lifestyle; thus the assumption
that increased exercise improves intestinal transit time. Such
patients should also increase their ﬂuid intake (1.5–2 L/day)
and ﬁber (25 g/day). However, attempts to obtain improvement
of slow transit constipation with ﬁber supplements are usu-
ally unsuccessful, despite many  studies that have tested the
use of ﬁber in the diet of subjects with chronic constipation
that pointed in the opposite direction.2,3,16,47,48
Medical  therapy
Laxants
For many  constipated patients, the use of laxatives is a con-
stant reality. Besides the use of ﬁber in the diet, several studies
have already proven the effectiveness of osmotic and stim-
ulant laxatives in chronic constipation, because these drugs
improve some symptoms and accelerate the intestinal transit.
While laxatives have a signiﬁcant impact on the frequency and
form of the stool, these drugs have little effect on abdominal
pain, sense of abdominal distension, the feeling of complete
evacuation, and efforts made to defecate (which may suggest
the presence of a concurrent defecatory obstruction).
Typically, one begins the treatment with ﬁber and an
osmotic laxative (i.e., magnesium salt or polyethylene glycol)
and, if necessary, with the addition of a stimulant laxative (i.e.
bisacodyl) .16,35,47,48
Prokinetics  and  intestinal  secretagogues
Prokinetics and intestinal secretagogues are agents that can
restore the colon function in cases of constipation.
Prokinetics accelerate the colonic transit and have laxa-
tive potential when inducing quick excitatory postsynaptic
potentials in intrinsic neurons, releasing excitatory neuro-
transmitters, and activating submucosal neurons, which leads
to an increased mucosal secretion. The highly selective ago-
nists of the 5-HT4 receptor (i.e. prucalopride, naronapride, and
velusetrag), besides being very effective, have a better safety
proﬁle, especially for cardiovascular system.
The use of prucalopride (so far the best-studied drug)
should be considered when symptomatic relief is not obtained
after the change of lifestyle and the use of laxatives. However,
and despite leading to the generation of high-amplitude prop-
agating contractions in the colon, its effect on the slow transit
constipation is not what is expected.c Inertia: approach and treatment. J Coloproctol (Rio J). 2016.
Intestinal secretagogues are useful for alleviating constipa-
tion, taking into account the production of softer stools and
intestinal transit acceleration by reducing the effort to defe-
cate. These drugs promote intestinal secretion activation in
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two different ways. On the one hand, type 2 intestinal chlo-
ride channels can be activated by promoting secretion of ﬂuid
(lubiprostone). On the other hand, by acting on the guanylyl
cyclase receptors of enterocytes, these drugs potentiate the
increase in chloride and bicarbonate secretion into the intesti-
nal lumen (linaclotide).6,7,13,16,47,48
Other  pharmaceuticals
It may be advantageous to treat a possible bacterial overgrowth
with antibiotics, due to the reduced intestinal transit.
The effects of probiotics in chronic idiopathic constipa-
tion are not well known, but it is thought that these effects
will modestly decrease the intestinal transit in constipated
patients.16,47,49
Nerve  stimulation
Neuromodulator therapy, or sacral nerve stimulation, is an
established treatment in urological pathology (incontinence
and retention) and in fecal incontinence. Studies that tested
its applicability in slow transit constipation have shown
promising results, as there is a direct involvement in the
pathophysiology of the disease. Despite this, the underlying
mechanisms are not completely understood, and it is believed
that the action occurs in central, sensory and motor lev-
els. Apparently, this technique induces pan-colonic pressure
waves (including sequences of retrograde propagation, which
at ﬁrst may seem counterproductive).
The great advantage of this technique is that it allows the
testing of results and the effectiveness of a temporary stim-
ulation, pre-selecting patients who will receive a permanent
implant (a 3-week temporary stimulation appears to have a
higher negative than positive predictive value, but perhaps
there is a need for a longer treatment, to obtain results).
Strict selection criteria for the application of this technique
are not established. In general, the technique is applied when
the conventional therapy failed. A better understanding of
the pathophysiology allows a better selection of patients and,
therefore, better results (some studies report that the results
will be better in the presence of an isolated or concomitant
defecatory obstruction).
The stimulation site varies from the transcutaneous stimu-
lation to the direct stimulation of speciﬁc nerves. Normally S3
is the stimulated nerve, but it is thought that the stimulation
of posterior tibial nerve ﬁbers, by containing 2nd and 3rd nerve
roots, will be of potential interest, thanks to the easy acces-
sibility of the nerve. There is no consensus as to the optimal
stimulation. Oversensitive stimulus levels appear to be more
effective, but more  studies are needed to test the subsensi-
tive stimulation that would be more  tolerable and, therefore,
more attractive to patients. A study in dogs found that the
use of pulse waves, a technique used in most animal studies,
will be more  effective than the use of long isolated repeti-
tive pulses, which is the technique normally used in humanPlease cite this article in press as: Soares AS, Barbosa LE. Coloni
http://dx.doi.org/10.1016/j.jcol.2016.05.006
studies. A deepening of the knowledge related to meth-
ods of direct electrical stimulation (intramuscular, serous or
intraluminal) of the colon, and of interferential therapy for
treatment of slow-transit constipation in adults (stimulation6;x x x(x x):xxx–xxx
of the parasympathetic ﬁbers increases the colonic transit) is
required.14,16,33,47,50–57
Other  options
Other options that should be considered in relieving symp-
toms and that induce some improvements in chronic
constipation are rectal/transanal irrigation (its advantages
include: a less invasive technique versus surgery, it cleans
the bowel more  proximally versus enemas, it can be done
on an outpatient basis, and the patient can decide the fre-
quency and timing of the procedure, allowing a greater control
of symptoms), or anterograde colon enemas (which should be
considered for patients who are satisﬁed with the results of
the rectal irrigation, but who ﬁnd it inconvenient).47,58
Surgical  options
The American Gastroenterological Association recommends
surgical intervention for patients with symptomatic slow tran-
sit constipation where the colonic motor dysfunction has been
appropriately documented (manometry, barostat) and in cases
whose long and aggressive therapy with laxatives, ﬁber, and
prokinetic agents failed (proof of refractoriness to medical
treatment).10,36
Some studies claim that the ﬁnding of manometric char-
acteristics of neuropathy constitutes a surgical indication,
whereas this option should be discouraged in patients with a
normal colonic manometry, or a with manometry suggestive
of myopathy.3,8,11,47
The two main surgical treatments for slow transit con-
stipation are total colectomy with ileorectal anastomosis
and subtotal colectomy. A segmental colectomy may also be
performed.1,11,59
Total  colectomy  with  ileorectal  anastomosis
This is the surgery of choice for colic inertia. When one opts for
a total colectomy, the anastomosis is made at the superior rec-
tum by laparotomy, laparoscopy or hand-assisted laparoscopy.
As most of the patients are young and active, they are good
candidates for a laparoscopic surgery, with the advantages
associated with this procedure.
A proper selection of patients for this surgery results in
excellent outcomes (exceeding 85–90%). However, other stud-
ies show that patient satisfaction levels vary widely (39–100%);
it is likely that this has to do with the possibility of some degree
of persistence of symptoms and morbidity. The most frequent
postoperative complication is a small bowel obstruction (by
occlusion or neuropathic dysfunction of the myenteric plexus,
which affects intestinal motility). The mortality of this surgery
is also variable. Some studies report less than 1%,  while in
other the mortality ranges from 0 to 15%.1,3,11,12,15,34,52,59–61
Subtotal  colectomy
This surgery is a valid alternative for some patients. The
resection is carried out at a point about 10 cm distally to thec Inertia: approach and treatment. J Coloproctol (Rio J). 2016.
ileocecal junction and in the upper part of the rectum. The
preservation of the terminal ileum, ileocecal valve and cecum
permits the reabsorption of electrolytes, bile salts, vitamin B12
and about 2 L of water per day. In terms of efﬁcacy and safety,
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his technique appears to be similar to total colectomy with
leorectal anastomosis, with lower rates of diarrhea and post-
urgical incontinence. However, preservation of the ileocecal
alve and cecum appears to result in a higher rate of recurrent
r persistent constipation.
Colonic reservoirs of different sizes may be created, but
here is still no consensus about what is the best option.
owever, it seems that the shortening of the ascending colon
ortion above the ileocecal junction results in a better qual-
ty of life (less distention of the cecum and less abdominal
ain).1,3,47,59–61
egmental  colectomy
lthough an attractive option, it is difﬁcult to determine, by
eans of transit studies, in which speciﬁc part of the colon
ccurs the dysmotility, or if it occurs throughout the colon,
hich may lead to recurrence of symptoms and to persis-
ent constipation; also, an additional surgical resection may
e needed. The same problem occurs in patients treated with
ubtotal colectomy.1
iscussion
nvestigations and observations conducted on patients with
olic inertia led to the proposal of various etiologies, suggest-
ng the existence of multiple causes. However, to determine
f some of them are the cause or consequence of the disease
s a challenging task. This question is particularly relevant in
elation to the ﬁndings related to myopathy, since the vast
ajority of studies suggest the existence of neuropathy (lead-
ng consequently to the belief that the primary cause lies at
his point). It would be important to have a concatenated, com-
rehensive and integrated view of the mechanisms, in order to
larify which changes are occurring, particularly at the level
f enteric nervous transmission, regulation and modulation
ith food intake, and a possible role of clock genes.
In view of the predominance of cases in young women, it
ould be interesting to investigate the possible occurrence of
 variety of complaints with menstrual cycle and its relation
ith the overexpression of progesterone receptors. This may
roject a new focus on different therapeutic targets.
Despite the fact that the evolution of manometry allowed
n in-depth knowledge of the propagation characteristics of
he colon, there is still no standardization of the technique,
hich can result in a potential loss of relevant information. It
ould be appropriate to clarify whether the retrograde prop-
gation sequences have some active etiological role.
As mentioned earlier, some studies state that neuropathic
haracteristics obtained with colonic manometry constitute
n indication for surgery, while patients with a normal colonic
anometry, or one suggestive of myopathy are not candidates
or surgery. One why is this, because patients with myopathic
eatures could beneﬁt from a more  localized intervention.
Standardization in the evaluation of the results of dif-
erent surgical interventions is very important, in order toPlease cite this article in press as: Soares AS, Barbosa LE. Coloni
http://dx.doi.org/10.1016/j.jcol.2016.05.006
btain a more  accurate assessment of the advantages and
isadvantages of each procedure, in the decision-making
f an individualized therapeutic choice. If the surgeon has
o choose a surgical treatment, the advantage offered by a;x x x(x x):xxx–xxx 7
segmental colectomy is undeniable, because in this situation
this would allow the most conservative therapy possible.
Therefore, we must emphasize the importance of the vari-
ous complementary diagnostic studies, not only to conﬁrm
the surgical indication but also for the exclusion of other
comorbidities that could be associated with a worse outcome.
A broader understanding of the pathophysiology also
allows a better selection of patients for sacral nerve stimula-
tion, which is an attractive alternative therapy versus surgery.
The stimulation of different nerve roots and the direct stimu-
lation of the colon would help circumvent the fact that sacral
nerve stimulation seems to produce better results in the case
of defecatory obstruction or in patients in whom this condition
occurs simultaneously with the slow transit constipation.
Conclusion
Although the medical community has witnessed a consider-
able improvement in understanding the pathophysiology of
colic inertia over the past years, this is still insufﬁcient. The
evolution of slow transit constipation as a pathology should be
further studied, in order to eventually ﬁnd predictive markers
of its progression, as well as ways to prevent the worsening of
this condition.
It is mandatory to register the lines of conduct that should
be taken into account in the guidance of these patients; and
it is essential to ﬁnd new clinical targets, particularly consid-
ering that this entity affects a signiﬁcant percentage of the
population, in whom the most affected individuals are young
people, and also because the end of the therapeutic line is a
surgical procedure.
More studies providing a global perspective are welcome.
A more  consistent bet in randomized clinical trials, in order to
produce higher-value scientiﬁc evidence, could result in more
effective therapeutic implementations.
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